Rubius Therapeutics, Inc. EBITDA 2018-2022 | RUBY
Rubius Therapeutics, Inc. ebitda from 2018 to 2022. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.
| Rubius Therapeutics, Inc. Annual EBITDA (Millions of US $) |
|
|---|---|
| 2022 | $-172 |
| 2021 | $-187 |
| 2020 | $-161 |
| 2019 | $-167 |
| 2018 | $-90 |
| 2017 | $-43 |
| 2016 | $-11 |
| Rubius Therapeutics, Inc. Quarterly EBITDA (Millions of US $) |
|
|---|---|
| 2022-12-31 | $-23 |
| 2022-09-30 | $-59 |
| 2022-06-30 | $-41 |
| 2022-03-31 | $-49 |
| 2021-12-31 | $-50 |
| 2021-09-30 | $-49 |
| 2021-06-30 | $-48 |
| 2021-03-31 | $-39 |
| 2020-12-31 | $-39 |
| 2020-09-30 | $-39 |
| 2020-06-30 | $-36 |
| 2020-03-31 | $-47 |
| 2019-12-31 | $-45 |
| 2019-09-30 | $-48 |
| 2019-06-30 | $-41 |
| 2019-03-31 | $-34 |
| 2018-12-31 | $-29 |
| 2018-09-30 | $-27 |
| 2018-06-30 | $-20 |
| 2018-03-31 | $-14 |
| 2017-09-30 | $-12 |
| 2017-06-30 | $-9 |
